Search results
Combining SGLT2 Meds And GLP-1 Drugs Like Ozempic Can Help Reduce Risks Of Heart Attack, Stroke;...
Times Now· 3 hours agoA new study published in The Lancet Diabetes & Endocrinology shows that SGLT2 inhibitors and GLP-1...
Diabetes: Symptoms, Types, Risk Factors And More About The Disease
Times Now· 2 days agoDiabetes is a condition wherein your blood sugar (glucose) levels are high. A person usually...
Eating 30% Less of One Type of Meat Could Prevent Future Type 2 Diabetes
ScienceAlert· 1 day agoOver the next decade, public health data suggests a 30 percent reduction in processed meat – cutting...
Weight loss is among the ‘best routes to diabetes remission’
The Hindu· 4 hours agoSeveral organisations across the world have accepted the term ‘Remission of Diabetes‘. Most of us...
Ozempic Better Than Insulin In Lowering The Risk Of Certain Cancers In Those With Type-2 Diabetes,...
Times Now· 6 days agoPatients with type-2 diabetes can significantly lower their risk for certain obesity-related cancers...
Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows - ET HealthWorld
The Economic Times· 6 days agoLondon: Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower...
Can weight loss drugs help in reducing risk of alcohol use disorder?
Indian Express· 1 hour agoHow does semaglutide reduce alcohol craving? Semaglutide belongs to a class of drugs called...
From banning junk food ads to a sugar tax: with diabetes on the rise, we can’t afford to ignore the...
Hindustan Times· 6 days agoThis time the recommendations come from a parliamentary inquiry into diabetes in Australia. The...
After AdCom rejection, FDA rebuffs Novo Nordisk’s once-weekly insulin
Pharmaceutical Technology· 12 hours agoThe AdCom did not discuss the use of the drug for treating type 2 diabetes (T2D). Once-weekly...
Novo’s once-weekly insulin rejected by FDA
BioPharma Dive· 18 hours agoThe FDA’s decision to turn back the drugmaker’s new insulin product narrows Novo’s lead in the U.S. over Eli Lilly, which has a similar diabetes...